Head and Neck Neoplasm Clinical Trial
Official title:
A Pilot Study of Whole-Neck CT Perfusion With the Toshiba Aquilion ONE ViSION-320 Detector Row CT Scanner for Use in Head &Amp; Neck Tumor Patients
This pilot clinical trial studies how well whole-neck computed tomography perfusion scans work in imaging patients with head and neck tumors. Diagnostic imaging procedures, such as whole-neck computed tomography perfusions scans, may provide more information about the blood supply to head and neck tumors which may help doctors plan better treatment.
PRIMARY OBJECTIVES: I. To assess the difference in whole-neck computed tomography perfusion (WNCTP) parameters (blood volume [BV], blood flow [BF], capillary permeability [CP] and mean transit time [MTT]) between head and neck tumor masses (benign or malignant) and adjacent normal skeletal muscle within the same patient. II. To assess whether the difference in WNCTP parameters between tumor masses and adjacent normal skeletal muscle is different between patients with benign tumor versus (vs.) malignant tumor. III. To assess the correlation in WNCTP parameters between tumor masses and adjacent normal skeletal muscle. IV. Determine if more suspicious cervical lymph nodes will be seen using the whole-neck coverage employed in WNCTP compared to the limited coverage of traditional neck CTP. OUTLINE: Patients undergo WNCTP scan over 2-3 minutes during standard of care computed tomography (CT). After completion of study, patients are followed up within 2 days. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02602067 -
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
|
Phase 1 | |
Completed |
NCT04277273 -
Characteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de Paris
|
N/A | |
Completed |
NCT03896906 -
Preoxygenation With a High-flow Nasal Cannula or a Simple Mask Before General Anesthesia in Head and Neck Surgery
|
N/A | |
Completed |
NCT01621295 -
Assessing the Patient Experience in Cancer Care
|
N/A | |
Active, not recruiting |
NCT03854838 -
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.
|
Phase 2 | |
Completed |
NCT04151030 -
Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure
|
N/A | |
Completed |
NCT03012581 -
Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
|
Phase 2 | |
Active, not recruiting |
NCT04005521 -
Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer
|
N/A | |
Recruiting |
NCT05011500 -
Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC)
|
N/A | |
Completed |
NCT05590650 -
A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients
|
Phase 1 | |
Terminated |
NCT03402737 -
SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N
|
N/A | |
Completed |
NCT04086849 -
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
|
||
Completed |
NCT00001442 -
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
|
Phase 1 | |
Recruiting |
NCT04477759 -
Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer
|
Phase 1 | |
Terminated |
NCT00423150 -
Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)
|
Phase 2 | |
Recruiting |
NCT03757091 -
Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery
|
N/A | |
Recruiting |
NCT04099290 -
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
|
||
Withdrawn |
NCT04679233 -
Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients
|
N/A | |
Not yet recruiting |
NCT04267627 -
Telemedicine Nurse-Led Intervention for Rural Cancer Survivors
|
N/A | |
Completed |
NCT00666926 -
Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms
|
Phase 1 |